Hi Rob and Ruth,
Thank you for the compliment, Ruth
! Since I was 67 yo when I was dx I have not read much about SCT or BMT but I have tried to find some references. One is from fall 2008 but the other is quite old (2001). They obviously still don´t know the answer.
When you see the high mortality rates, Rob, you should realize that many patients have AML, that is a very dangerous disease.
https://www.team-psa.com/DOT/fall200...ment%20N31.doc
http://bloodjournal.hematologylibrar...ull/98/10/2900
Conclusion from the article from 2001: "
Does the stem cell source matter? Favorable disease-free survival rates after SCT, particularly in patients with advanced-stage cancer, give SCT an advantage over BMT. "
Kind regards
Birgitta-A